Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Lexington, Kentucky 40502


Purpose:

This placebo-controlled, double-blind, randomized pilot clinical trial will evaluate atomoxetine (Strattera®) for the treatment of cocaine dependence. Cocaine-dependent individuals, who are healthy and are seeking treatment for their substance abuse, will be randomized to receive either atomoxetine (n=25) or a matched-placebo (n=25) during a trial lasting 12 weeks; there will be a double-blind, ascending dose lead-in order to achieve maintenance on the assigned active dose safely. Contingency management procedures will be used to reinforce attendance and compliance with study procedures. Primary outcome measures will include urinalysis data assessing cocaine use.


Criteria:

Inclusion Criteria: - Seeking treatment for cocaine dependence - Must have used cocaine in the past 30 days Exclusion Criteria: - Physical dependence on any drug requiring medical management - Any major medical or psychiatric disorder that would be contraindicated for participation - Cardiovascular disease - Seizures or significant head injuries - Currently taking atomoxetine - Pregnant or breast-feeding


NCT ID:

NCT00617201


Primary Contact:

Principal Investigator
Sharon L Walsh, Ph.D.
University of Kentucky


Backup Contact:

N/A


Location Contact:

Lexington, Kentucky 40502
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: March 16, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.